Adult Attention-Deficit/Hyperactivity Disorder and the Risk of Dementia.
Journal
JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235
Informations de publication
Date de publication:
02 10 2023
02 10 2023
Historique:
medline:
23
10
2023
pubmed:
17
10
2023
entrez:
17
10
2023
Statut:
epublish
Résumé
Evidence that adult attention-deficit/hyperactivity disorder (ADHD) is associated with an increased risk of dementia is scarce and inconsistent, and potential sources of bias are untested. To examine the association between adult ADHD and the risk of dementia. This prospective national cohort study consisted of 109 218 members of a nonprofit Israeli health maintenance organization born between 1933 and 1952 who entered the cohort on January 1, 2003, without an ADHD or dementia diagnosis and were followed up to February 28, 2020. Participants were aged 51 to 70 years in 2003. Statistical analysis was conducted from December 2022 to August 2023. Adult ADHD was a time-varying covariate, classified as present from the age of the first diagnosis (using the International Classification of Diseases, Ninth Revision, and the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision); otherwise, absent. Cox regression models were fitted to quantify the association between adult ADHD and the risk of incident dementia with hazard ratios (HRs) and their 95% CIs unadjusted and in the primary analysis, using inverse probability weights, adjusted for 18 sources of potential confounding. In 14 complementary analyses, subgroup and sensitivity analyses were implemented. At the beginning of the follow-up, the sample of 109 218 participants had a mean (SD) age of 57.7 (5.5) years, 56 474 participants (51.7%) were female, and 52 744 (48.3%) were male. During follow-up, 730 participants (0.7%) received a diagnosis of adult ADHD, and 7726 (7.1%) received a diagnosis of dementia. Dementia occurred among 96 of 730 participants (13.2%) with adult ADHD and 7630 of 108 488 participants (7.0%) without adult ADHD. In the primary analysis, compared with the absence of adult ADHD, the presence of adult ADHD was statistically significantly (P < .001) associated with an increased dementia risk (unadjusted HR, 3.62 [95% CI, 2.92-4.49; P < .001]; adjusted HR, 2.77 [95% CI, 2.11-3.63; P < .001]). Twelve of the 14 complementary analyses did not attenuate the conclusions based on the results of the primary analysis. There was, however, no clear increase in the risk of dementia associated with adult ADHD among those who received psychostimulant medication, and evidence of reverse causation was mild. In this cohort study of individuals born between 1933 and 1952 and followed up in old age, adult ADHD was associated with an increased risk of dementia. Policy makers, caregivers, patients, and clinicians may wish to monitor reliably for ADHD in old age.
Identifiants
pubmed: 37847497
pii: 2810766
doi: 10.1001/jamanetworkopen.2023.38088
pmc: PMC10582792
doi:
Substances chimiques
Central Nervous System Stimulants
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2338088Références
Am J Psychiatry. 2015 Oct;172(10):967-77
pubmed: 25998281
N Engl J Med. 2020 Sep 10;383(11):1050-1056
pubmed: 32905677
Clin Psychol Rev. 2013 Mar;33(2):215-28
pubmed: 23298633
Alzheimers Dement. 2018 May;14(5):601-609
pubmed: 29169013
Int Psychogeriatr. 2019 Jul;31(7):1059-1063
pubmed: 30318021
JAMA Psychiatry. 2016 Jul 1;73(7):713-20
pubmed: 27192174
Neurosci Biobehav Rev. 2020 Nov;118:282-289
pubmed: 32798966
J Nerv Ment Dis. 2014 Oct;202(10):725-31
pubmed: 25211634
Neurochem Int. 2018 Jan;112:255-258
pubmed: 28811268
Nat Rev Dis Primers. 2021 May 13;7(1):33
pubmed: 33986301
JAMA Psychiatry. 2016 Jul 1;73(7):705-12
pubmed: 27192050
J Atten Disord. 2019 Jul;23(9):995-1006
pubmed: 28629260
Alzheimers Dement. 2022 Jun;18(6):1155-1163
pubmed: 34498801
Int J Epidemiol. 1989 Mar;18(1):269-74
pubmed: 2656561
Am J Geriatr Psychiatry. 2023 May;31(5):315-323
pubmed: 35718587
Alzheimers Dement. 2013 Jan;9(1):63-75.e2
pubmed: 23305823
Eur Psychiatry. 2021 Dec 20;:1-19
pubmed: 34924079
Pharmacopsychiatry. 2020 Apr;53(3):109-114
pubmed: 32000270
BMJ. 1995 Feb 18;310(6977):454-6
pubmed: 7873955
Am J Geriatr Psychiatry. 2019 Nov;27(11):1177-1188
pubmed: 31235427
Lancet. 2020 Aug 8;396(10248):413-446
pubmed: 32738937
Arch Gen Psychiatry. 1998 Sep;55(9):809-15
pubmed: 9736007
J Atten Disord. 2012 May;16(4):333-8
pubmed: 22173147
Lancet Neurol. 2014 Aug;13(8):788-94
pubmed: 25030513
Eur J Neurol. 2011 Jan;18(1):78-84
pubmed: 20491888
Alzheimers Dement. 2022 Apr;18(4):700-789
pubmed: 35289055
J Aging Res. 2011;2011:729801
pubmed: 21822493
Eur Psychiatry. 2019 Feb;56:14-34
pubmed: 30453134
Stat Med. 1998 Sep 15;17(17):1973-88
pubmed: 9777690
J Psychiatr Res. 2020 Apr;123:21-30
pubmed: 32014701